Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin vs Tranexamic Acid in Cardiac Surgery
NCT00396760Phase 3Unknown
- Sponsor
- Deutsches Herzzentrum München
- Start
- Jan 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aprotinin and tranexamic acid in postoperative hemorrhage, sponsored by Deutsches Herzzentrum München. Primary endpoints: 24 hours postoperative drainage blood loss and Incidence of allogeneic blood transfusion. Status: unknown.
02
Drugs
aprotinintranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT00396760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396760.